{
    "2021-12-29": [
        [
            {
                "time": "",
                "original_text": "十公司年内获上千家机构调研，迈瑞医疗、汇川技术最受关注",
                "features": {
                    "keywords": [
                        "机构调研",
                        "迈瑞医疗",
                        "汇川技术"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "技术"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "顶层设计出台——“十四五”医疗装备规划，七大领域将受益！",
                "features": {
                    "keywords": [
                        "顶层设计",
                        "十四五",
                        "医疗装备",
                        "七大领域"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "中国区域金融力排行榜：北京登顶，江浙紧逼",
                "features": {
                    "keywords": [
                        "区域金融力",
                        "北京",
                        "江浙"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "西南证券医药2022年度策略：未来医药估值有望均衡，“穿越医保”和“疫情脱敏”是两条核心主线",
                "features": {
                    "keywords": [
                        "西南证券",
                        "医药",
                        "估值均衡",
                        "穿越医保",
                        "疫情脱敏"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}